CL2022001169A1 - Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto - Google Patents

Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto

Info

Publication number
CL2022001169A1
CL2022001169A1 CL2022001169A CL2022001169A CL2022001169A1 CL 2022001169 A1 CL2022001169 A1 CL 2022001169A1 CL 2022001169 A CL2022001169 A CL 2022001169A CL 2022001169 A CL2022001169 A CL 2022001169A CL 2022001169 A1 CL2022001169 A1 CL 2022001169A1
Authority
CL
Chile
Prior art keywords
cation exchange
exchange chromatography
high salt
product related
related impurities
Prior art date
Application number
CL2022001169A
Other languages
English (en)
Spanish (es)
Inventor
Natalia Gomez
Malhar R Ambhaikar
Benjamin J Tillotson
Luis Diaz
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2022001169A1 publication Critical patent/CL2022001169A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CL2022001169A 2019-11-07 2022-05-04 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto CL2022001169A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962931874P 2019-11-07 2019-11-07

Publications (1)

Publication Number Publication Date
CL2022001169A1 true CL2022001169A1 (es) 2023-01-27

Family

ID=73598212

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2022001169A CL2022001169A1 (es) 2019-11-07 2022-05-04 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto
CL2024001792A CL2024001792A1 (es) 2019-11-07 2024-06-14 Métodos purificación proteínas con lavados altos en nacl en cromatografía intercambio catiónico

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2024001792A CL2024001792A1 (es) 2019-11-07 2024-06-14 Métodos purificación proteínas con lavados altos en nacl en cromatografía intercambio catiónico

Country Status (14)

Country Link
US (1) US20220372071A1 (cg-RX-API-DMAC7.html)
EP (1) EP4055042A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022554283A (cg-RX-API-DMAC7.html)
KR (1) KR20220092958A (cg-RX-API-DMAC7.html)
CN (1) CN114651007A (cg-RX-API-DMAC7.html)
AR (1) AR120398A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020377919A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022008782A2 (cg-RX-API-DMAC7.html)
CA (1) CA3160208A1 (cg-RX-API-DMAC7.html)
CL (2) CL2022001169A1 (cg-RX-API-DMAC7.html)
IL (1) IL292602A (cg-RX-API-DMAC7.html)
MX (1) MX2022005594A (cg-RX-API-DMAC7.html)
TW (1) TWI878377B (cg-RX-API-DMAC7.html)
WO (1) WO2021091933A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023007028A (es) * 2020-12-18 2023-09-21 Kiniksa Pharmaceuticals Ltd Composiciones de proteínas y métodos para producir y usar las mismas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555661B1 (en) * 1997-08-25 2003-04-29 Anthony R. Torres Simple, environmentally benign, method for purifying protein A
HUE024877T2 (en) * 2007-10-30 2016-02-29 Genentech Inc Antibody purification by cation exchange chromatography
US20120282654A1 (en) * 2009-04-29 2012-11-08 Schering Corporation Antibody purification
US20120238730A1 (en) * 2011-03-15 2012-09-20 Abbott Laboratories Integrated approach to the isolation and purification of antibodies
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业(上海)股份有限公司 重组蛋白质的纯化方法
WO2015198320A1 (en) * 2014-06-24 2015-12-30 Insight Biopharmaceuticals Ltd. Methods of purifying antibodies
PL3177643T3 (pl) * 2014-08-04 2019-09-30 F.Hoffmann-La Roche Ag Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
EP3204415B1 (en) * 2014-10-09 2020-06-17 EngMab Sàrl Bispecific antibodies against cd3epsilon and ror1
JP6699085B2 (ja) * 2015-03-25 2020-05-27 東ソー株式会社 Fc結合性タンパク質の精製方法
CA3026518A1 (en) * 2016-06-17 2017-12-21 Genentech, Inc. Purification of multispecific antibodies
JP2020525445A (ja) * 2017-06-21 2020-08-27 セファロン・インコーポレイテッドCephalon,Incorporated カチオン交換クロマトグラフィーの洗浄緩衝液
CN110305217B (zh) * 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
JP2022554283A (ja) 2022-12-28
JP2026048656A (ja) 2026-03-17
TWI878377B (zh) 2025-04-01
IL292602A (en) 2022-07-01
TW202523676A (zh) 2025-06-16
MX2022005594A (es) 2022-06-09
WO2021091933A1 (en) 2021-05-14
EP4055042A1 (en) 2022-09-14
AU2020377919A1 (en) 2022-06-16
US20220372071A1 (en) 2022-11-24
TW202132323A (zh) 2021-09-01
CL2024001792A1 (es) 2024-11-08
KR20220092958A (ko) 2022-07-04
CA3160208A1 (en) 2021-05-14
BR112022008782A2 (pt) 2022-07-26
AR120398A1 (es) 2022-02-09
CN114651007A (zh) 2022-06-21

Similar Documents

Publication Publication Date Title
RS67828B1 (sr) Konfiguracija za proizvodnju olefina
SG11202103485PA (en) Low beam headlights
HUE055703T2 (hu) Eljárás hialuronsav tisztítására
EP4014502A4 (en) SCALING METHOD FOR ENCODER BLOCK
ZA202109175B (en) Novel peptide compound or pharmaceutically acceptable salt thereof
EP4410773A3 (en) Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid
SG11202103001PA (en) Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
MX373659B (es) Metodo para producir un pentapeptido sintetico.
PL3823952T3 (pl) Oczyszczanie kwasu lewulinowego
BR112016013157A2 (pt) peptídeos resistentes à protease
PT3737470T (pt) Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40
MY198138A (en) Process For Pd-Catalyzed Hydroxycarbonylation Of Diisobutene: Ratio Of 3,5,5-Trimethylhexanoic Acid/H2O
IL281761A (en) Process of making calcium alpha-ketoglutarate
PL3272760T3 (pl) Ligandy 1,1'-bis(fosfino)ferrocenowe dla alkoksykarbonylowania
SG11202007168TA (en) Industrial process for continuously synthesizing alkane-sulphonic acid
SG11202101575TA (en) Process for the production of high purity isobutylene
MX2022005594A (es) Lavados de salinidad elevada durante cromatografia de intercambio cationico para eliminar impurezas relacionadas con el producto.
GB2576235B (en) Workbench system
MX381459B (es) Metodo de manufactura de proteina.
MX2019005785A (es) Proceso para la purificacion de 1-(4-clorofenil)pirazol-3-ol.
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
PT3441429T (pt) Soluções de sal de leucoindigo aquoso purificado concentrado
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.
IT201900025186A1 (it) Metodo per la purificazione di cisteammina
CL2022001168A1 (es) Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto